VYNE Therapeutics

$7.63
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.19 (+2.55%) As of 4:40 PM UTC today

Why Robinhood?

You can buy or sell VYNE and other stocks, options, and ETFs commission-free!

About VYNE

VYNE Therapeutics, Inc. engages in the manufacture of pharmaceutical products. It develops and commercialize solutions using its proprietary Molecule Stabilizing Technology. Its commercial products include AMZEEQ and ZILXI. The company is headquartered in Bridgewater, NJ. The listed name for VYNE is VYNE Therapeutics Inc. Common Stock.

CEO

David Domzalski

Employees

Headquarters

Bridgewater, New Jersey

Founded

—

Market Cap

437.85M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.76M

High Today

$7.80

Low Today

$7.47

Open Price

$7.56

Volume

536.97K

52 Week High

$17.96

52 Week Low

$4.00

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

VYNE Earnings

-$0.95

-$0.63

-$0.32

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Mar 4, Pre-Market

Preview Earnings Call